Tela Bio Inc (TELA) Stock Price, Quote & News

Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex...

Industry: Medical Devices

Sector: Healthcare

Phone: 484 320 2930

Website: www.telabio.com

Address:

1 Great Valley Parkway, Suite 24, Malvern, United States

stockanalysis_ Jun. 30 at 11:13 PM

After Hours Losers: $PET $ONEG $GVH $TELA $QMCO View the entire list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading

0 · Reply

LewisDaKat Jun. 4 at 7:25 PM

$TELA $TELA News TELA Bio Expands Presence in Europe with Launch of OviTex Inguinal for Minimally Invasive, Robotic Hernia Repairhttps://marketwirenews.com/news-releases/tela-bio-expands-presence-in-europe-with-launch-of-o-6102368112078638.html

0 · Reply

prismmarketview Jun. 4 at 5:50 PM

$TELA https://prismmarketview.com/tela-bio-expands-presence-in-europe-with-launch-of-ovitex-inguinal-for-minimally-invasive-robotic-hernia-repair/

0 · Reply

MakingMeMeoutofME Jun. 4 at 5:39 PM

$MLSS .92 going to grab a strong CEO? Look at $TELA 1.00 to 2.01 new president hire from Abiomed

1 · Reply

WhateverMan741 Jun. 4 at 3:59 PM

$TELA Regret :D

0 · Reply

RocketThief Jun. 4 at 3:47 PM

$TELA sold some on this pop but still have a position, only $75 MC so lots of upside if they execute

0 · Reply

DonCorleone77 Jun. 3 at 8:49 PM

$TELA Tela Bio announces European launch of OviTex Inguinal Reinforced Tissue Matrix Tela Bio announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair.

0 · Reply

ridethewaves3 Jun. 3 at 7:49 PM

$TELA good time to get in….

0 · Reply

PenkeTrading May. 23 at 7:37 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Tela Bio Inc. Is that bullish or bearish? $TELA #RsiOverbought #NASDAQ

0 · Reply

RocketThief May. 20 at 3:08 PM

$TELA delayed reaction to the better Q?

0 · Reply

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 3, 2025, 4:05 PM EDT - 4 weeks ago

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

Jun 2, 2025, 8:30 AM EDT - 4 weeks ago

TELA Bio Appoints Jeffrey Blizard as President

May 22, 2025, 4:05 PM EDT - 6 weeks ago

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

May 11, 2025, 3:30 PM EDT - 7 weeks ago

TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript

May 9, 2025, 4:05 PM EDT - 7 weeks ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 4:05 PM EDT - 2 months ago

TELA Bio to Announce First Quarter 2025 Financial Results

Mar 20, 2025, 10:04 PM EDT - 3 months ago

TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 4:05 PM EDT - 3 months ago

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 4:05 PM EST - 4 months ago

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

Nov 19, 2024, 4:05 PM EST - 8 months ago

TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 9, 2024, 1:49 PM EST - 8 months ago

TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 4:05 PM EDT - 9 months ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 23, 2024, 8:07 AM EDT - 9 months ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Oct 22, 2024, 4:05 PM EDT - 9 months ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Oct 17, 2024, 4:05 PM EDT - 9 months ago

TELA Bio to Announce Third Quarter 2024 Financial Results

Aug 12, 2024, 8:37 PM EDT - 11 months ago

TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 11 months ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

Jul 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Second Quarter 2024 Financial Results

Jun 4, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

May 20, 2024, 4:03 PM EDT - 1 year ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

May 11, 2024, 2:35 PM EDT - 1 year ago

TELA Bio, Inc. (TELA) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Reports First Quarter 2024 Financial Results

Apr 25, 2024, 7:00 AM EDT - 1 year ago

TELA Bio to Announce First Quarter 2024 Financial Results

Apr 15, 2024, 7:00 AM EDT - 1 year ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Apr 8, 2024, 7:00 AM EDT - 1 year ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Mar 21, 2024, 7:38 PM EDT - 1 year ago

TELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Mar 21, 2024, 7:00 AM EDT - 1 year ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Mar 20, 2024, 7:00 AM EDT - 1 year ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Feb 29, 2024, 7:00 AM EST - 1 year ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Jan 16, 2024, 2:34 AM EST - 1 year ago

TELA Bio: Looks Like A Buy, But Some Pieces Missing To Make This A Strong Buy

Dec 5, 2023, 7:00 AM EST - 1 year ago

TELA Bio to Take Part in Connecting the Dots

Nov 16, 2023, 7:00 AM EST - 1 year ago

TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 12, 2023, 1:42 AM EST - 1 year ago

TELA Bio, Inc. (TELA) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

TELA Bio Reports Third Quarter 2023 Financial Results

Oct 26, 2023, 7:00 AM EDT - 1 year ago

TELA Bio to Announce Third Quarter 2023 Financial Results

Sep 18, 2023, 4:05 PM EDT - 1 year ago

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

Aug 16, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

Aug 9, 2023, 9:00 PM EDT - 2 years ago

TELA Bio, Inc. (TELA) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:03 PM EDT - 2 years ago

TELA Bio Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

Jun 15, 2023, 7:00 AM EDT - 2 years ago

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

May 25, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Participate in the Jefferies Global Healthcare Conference

May 19, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 14, 2023, 12:21 PM EDT - 2 years ago

TELA Bio, Inc. (TELA) Q1 2023 Earnings Call Transcript

May 11, 2023, 4:02 PM EDT - 2 years ago

TELA Bio Reports First Quarter 2023 Financial Results

May 9, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

May 2, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Participate in the JMP Securities Life Sciences Conference

Apr 27, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce First Quarter 2023 Financial Results

stockanalysis_ Jun. 30 at 11:13 PM

After Hours Losers: $PET $ONEG $GVH $TELA $QMCO View the entire list here: https://stockanalysis.com/markets/afterhours/?ref=saveontrading

0 · Reply

LewisDaKat Jun. 4 at 7:25 PM

0 · Reply

prismmarketview Jun. 4 at 5:50 PM

$TELA https://prismmarketview.com/tela-bio-expands-presence-in-europe-with-launch-of-ovitex-inguinal-for-minimally-invasive-robotic-hernia-repair/

0 · Reply

MakingMeMeoutofME Jun. 4 at 5:39 PM

$MLSS .92 going to grab a strong CEO? Look at $TELA 1.00 to 2.01 new president hire from Abiomed

1 · Reply

WhateverMan741 Jun. 4 at 3:59 PM

$TELA Regret :D

0 · Reply

RocketThief Jun. 4 at 3:47 PM

$TELA sold some on this pop but still have a position, only $75 MC so lots of upside if they execute

0 · Reply

DonCorleone77 Jun. 3 at 8:49 PM

0 · Reply

ridethewaves3 Jun. 3 at 7:49 PM

$TELA good time to get in….

0 · Reply

PenkeTrading May. 23 at 7:37 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Tela Bio Inc. Is that bullish or bearish? $TELA #RsiOverbought #NASDAQ

0 · Reply

RocketThief May. 20 at 3:08 PM

$TELA delayed reaction to the better Q?

0 · Reply

ProBoxTV May. 10 at 1:10 AM

$TELA If next quarter goes well in terms of their top line, the share price will come back gradually. In 24, they had a dip in Q2, however in this year, they cannot afford to have this kind of dip to keep their share price at current level. I really hope they execute in Q2 but uncertainty is very high.

0 · Reply

Wisenheimer May. 9 at 11:30 AM

$TELA 4 quarters of cash left. They probably raise money in the next six months again have they ever suggested that they’re gonna get to breakeven or does this continue to get subsidized?

0 · Reply

WhateverMan741 May. 8 at 9:48 PM

$TELA Lmao I sold before earnings. Good job to everyone who held 🥳

0 · Reply

RocketThief May. 8 at 8:09 PM

$TELA they actually beat, I’m pleasantly surprised

0 · Reply

WAYWARD_SUN Apr. 6 at 12:01 AM

$TELA

0 · Reply

Rage_Against_The_Machine Mar. 31 at 11:20 AM

$TELA expands OviTex PRS with larger sizes - their 31% YoY growth in 2024 suggests surgeons are adopting this alternative to cadaveric tissue. New configurations may streamline complex procedures, but cash burn (-$41.6M FY2024) remains critical. Product innovation meets financial reality. https://www.sec.gov/Archives/edgar/data/1561921/000110465925029612/tm2510876d1_8k.htm

0 · Reply

PLATINUM_TRADES Mar. 27 at 7:56 PM

$TELA ignore the newbies... Beautiful upstart.. Nice money already🥊🥊🥊🥊

0 · Reply

PLATINUM_TRADES Mar. 27 at 2:37 PM

$TELA $1.38 to break next.. Bounce time from lows no one here... They'll be coming soon🚨🚨

0 · Reply

NVDAMillionaire Mar. 27 at 3:35 AM

$TELA Innovative soft-tissue repair tech. Seeing strong Euro growth. Might add to position on next dip. Long-term potential looks promising. superb article: https://beyondspx.com/article/tela-bio-s-mission-to-reshape-soft-tissue-repair

0 · Reply

ricpenno Mar. 25 at 6:59 PM

$TELA keep seeing 100k / 200k buys flashing through on this one. Must be near the bottom…

1 · Reply

d_risk Mar. 22 at 6:35 PM

$TELA - TELA Bio Inc. Common Stock - 10K - Updated Risk Factors TELA's 2025 10-K Risk Factors highlight decreased net losses but rising deficits, cybersecurity and supply chain threats, strategic product shifts, increased international revenue, expanded patent portfolio, and new regulatory and competitive challenges. #Risk https://d-risk.ai/TELA/10-K/2025-03-21

0 · Reply

PenkeTrading Mar. 22 at 8:31 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Tela Bio Inc. Is that bullish or bearish? $TELA #RsiOversold #NASDAQ

0 · Reply

Market Cap	75.55M
Revenue (ttm)	69.30M
Net Income (ttm)	-37.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-54.60%
Debt to Equity Ratio	2.28

Volume	21,800
Avg Vol	129,920
Day's Range	N/A - N/A
Shares Out	39.56M
Stochastic %K	89%
Beta	0.90
Analysts	Strong Sell
Price Target	$5.60